Abcellera Biologics Inc ABCL

$13.64 +0.81 (6.31%)

Valuation

Market cap
3,872,497,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
3,057,300
Avg volume
4,970,042
Day's range
$12.65 – $13.65
Shares out
306,611,000
Stochastic %K
100%
Beta
1.32
Analysts
Strong Sell
Price target
$16.82

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

XxZeeMoneyxX Oct 28, 10:53 PM
$ABCL This is starting to look like an amazing setup….. November 9th will be the catalyst to push us to 18 and up!
0 replies
erpy Oct 28, 8:27 PM
$ABCL Gorgeous!!!
0 replies
Ckkung71 Oct 28, 8:15 PM
$ABCL This how it looks like then penny traders don’t sell. Let it be…
0 replies
psyxopathis Oct 28, 8:04 PM
$ABCL now we need something in November and we are close to 20$ bwfore January. Long and strong 💪 Only problem i have with ABCL is i dont know if i ever gonna sell
0 replies
TradeWinner Oct 28, 7:59 PM
$ABCL cover your shorts and begone.
0 replies
Odoji Oct 28, 7:57 PM
$ABCL 💉
0 replies
Stocktradesmoon Oct 28, 7:22 PM
$ABCL ABcellera 🔥 🔥!!!
0 replies
Stocktradesmoon Oct 28, 7:09 PM
$ABCL $14’sss coming fast and then $15
0 replies